AU3761393A - Indole derivatives with antiviral activity - Google Patents

Indole derivatives with antiviral activity

Info

Publication number
AU3761393A
AU3761393A AU37613/93A AU3761393A AU3761393A AU 3761393 A AU3761393 A AU 3761393A AU 37613/93 A AU37613/93 A AU 37613/93A AU 3761393 A AU3761393 A AU 3761393A AU 3761393 A AU3761393 A AU 3761393A
Authority
AU
Australia
Prior art keywords
antiviral activity
indole derivatives
indole
derivatives
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37613/93A
Inventor
George Stuart Cockerill
Edward Littler
Martin John Slater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB929206056A priority Critical patent/GB9206056D0/en
Priority to GB9206056 priority
Priority to GB929206809A priority patent/GB9206809D0/en
Priority to GB9206809 priority
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU3761393A publication Critical patent/AU3761393A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
AU37613/93A 1992-03-20 1993-03-19 Indole derivatives with antiviral activity Abandoned AU3761393A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB929206056A GB9206056D0 (en) 1992-03-20 1992-03-20 Indole derivatives
GB9206056 1992-03-20
GB929206809A GB9206809D0 (en) 1992-03-27 1992-03-27 Indole derivatives
GB9206809 1992-03-27

Publications (1)

Publication Number Publication Date
AU3761393A true AU3761393A (en) 1993-10-21

Family

ID=26300558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37613/93A Abandoned AU3761393A (en) 1992-03-20 1993-03-19 Indole derivatives with antiviral activity

Country Status (4)

Country Link
EP (1) EP0630241A1 (en)
JP (1) JPH07504673A (en)
AU (1) AU3761393A (en)
WO (1) WO1993018765A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290378T (en) * 1993-12-23 2005-03-15 Lilly Co Eli Protein kinase C inhibitors
EP0675125A1 (en) * 1994-03-18 1995-10-04 Kyowa Hakko Kogyo Co., Ltd. A therapeutic agent for thrombocytopenia and indolocarbazole derivatives
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
PE91698A1 (en) * 1996-07-29 1998-12-24 Hoffmann La Roche substituted pyrroles
PE91498A1 (en) * 1996-07-29 1998-12-22 Hoffmann La Roche substituted pyrroles
PE91598A1 (en) 1996-07-29 1998-12-24 Hoffmann La Roche substituted pyrroles
SE9603283D0 (en) * 1996-09-10 1996-09-10 Astra Ab New compounds
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017200A1 (en) 1997-12-23 2001-08-22 Astrazeneca Ab Inhibitor compounds protein kinase C, pharmaceutically acceptable salts thereof, formulations comprising farmaceuitcas, usode the same and process for the synthesis of such compounds
AU2548699A (en) * 1998-02-23 1999-09-06 Rei Asakai Cell death inhibitors
SE9800835D0 (en) 1998-03-13 1998-03-13 Astra Ab New Compounds
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
EP1440069B1 (en) 2001-11-02 2007-08-15 Glaxo Group Limited 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
JP2005511573A (en) * 2001-11-02 2005-04-28 グラクソ グループ リミテッドGlaxo Group Limited 4- (5-membered) -heteroarylacylpyrrolidine derivatives as HCV inhibitors
GB0303319D0 (en) 2003-02-13 2003-03-19 Novartis Ag Organic compounds
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
DK1846406T5 (en) 2005-02-09 2011-10-31 Arqule Inc Maleimide derivatives, pharmaceutical compositions and methods for the treatment of cancer
WO2008117935A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
WO2009002806A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
CA2912546A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Compositions and methods for treatment of cancer
AU2008268613A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
JP2017524739A (en) 2014-07-17 2017-08-31 アンセルムInserm Method for treating neuromuscular junction related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
MC2096A1 (en) * 1989-02-23 1991-02-15 Hoffmann La Roche pyrroles substituted
DE3914764A1 (en) * 1989-05-05 1990-11-08 Goedecke Ag New bis(1H-indol-3-yl) maleinimide derivs. - are inhibitors of protein kinase C for treatment of cardiovascular, CNS and immune system disorders
IL94274D0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles

Also Published As

Publication number Publication date
WO1993018765A1 (en) 1993-09-30
EP0630241A1 (en) 1994-12-28
JPH07504673A (en) 1995-05-25

Similar Documents

Publication Publication Date Title
AU665877B2 (en) Imidazopyridines
AU653734C (en) Substituted 4-biphenylmethoxypyridine derivatives
AU653734B2 (en) Substituted 4-biphenylmethoxypyridine derivatives
AU693480B2 (en) K-252a derivatives which enhance neurotrophin-induced activity
AU583607B2 (en) Indole derivatives
AU661901B2 (en) Protein C derivatives
AU667924B2 (en) Heteroacetic acid derivatives
AU638496B2 (en) Acyl-biphenylyl-alkyl pyrimidine derivatives
AU677367B2 (en) Antiviral agent
AU651637B2 (en) Indole derivatives
AU671959B2 (en) Indole derivatives
AU644249B2 (en) Alpha-oxoacetamide derivatives
AU3351393A (en) Piperidine derivatives
PL329177A1 (en) Derivatives of azahexane ehxibiting antiviral activity
AU4654093A (en) Phototranschromic ink
AU3978693A (en) IV rack
AU3569493A (en) Pyrimidine derivatives and processes for the preparation thereof
AU1772295A (en) Pyrrolopyrimidine derivatives having pharmacological activity
GR3023817T3 (en) BIS-STAUROSPORINE AND K-252a DERIVATIVES.
NZ275968A (en) Substituted indole derivatives and medicaments
AU3820393A (en) 2,4-dioxoimidazolidine derivatives
AU2666795A (en) Novel substituted purinyl derivatives with immunomodulating activity
GB2266091B (en) Indole derivatives
AU4754093A (en) Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
PH27219A (en) Pyrimidine derivatives